Episode 2

Florida Market Telehealth Rule & Controlled Substances

During the 2019 legislative session, Florida passed Chapter 2019-137, Laws of Florida, which establishes standards of practice for telehealth services, including patient evaluations, record-keeping, and controlled substances prescribing. The law also authorizes out-of-state health care practitioners to perform telehealth services for patients in Florida. Signed by the Governor on June 25, 2019, this law became effective on July 1, 2019.

Out-of-state health care practitioners must be registered with the Florida Department of Health to perform telehealth services for patients in Florida.


Health care providers must be licensed within their scope of practice by the appropriate licensing body to practice telehealth in Florida.

Providers must also use two-way, interactive communication tools, such as live video, instead of email or audio-only communication. If you use Medicaid, your telehealth provider must be registered with the Florida Medicaid program to receive reimbursement for telehealth services. Florida doesn’t require private insurers to cover telehealth, so check with your insurance company to determine if you’re eligible for the service. Some of these regulations may be altered during the COVID-19 pandemic.


In Florida, telehealth providers are permitted to prescribe medications if the medications aren’t listed as controlled substances.


Telemedicine Rule, Rule 64B8-9.0141, F.A.C.Controlled substances shall not be prescribed through the use of telemedicine except for the treatment of psychiatric disorders. This provision does not preclude physicians from ordering controlled substances through the use of telemedicine for patients hospitalized in a facility licensed pursuant to Chapter 395, F.S.

However, there is one important exception to this rule: If you need a controlled substance to manage a mental health condition, your telehealth provider is allowed to prescribe it.


Before prescribing medication, your telehealth provider must conduct an evaluation and explain the risks and benefits of the medication to you.


Filling out a questionnaire before your telehealth appointment isn’t enough to satisfy the evaluation requirement, so you should expect the provider to ask multiple questions about your symptoms and health history.




This episode is also available as a blog post: https://healthcare-wiki.com/2021/06/22/florida-market-telehealth-rule/




A Carenodes Production.

About the Podcast

Show artwork for Value Based Care Advisory (VBCA)
Value Based Care Advisory (VBCA)

Listen for free

About your host

Profile picture for Alex Yarijanian

Alex Yarijanian

Alex Yarijanian is a visionary healthcare executive with over 15 years of experience in healthcare strategy, payer-provider relations, and value-based care models. As CEO and Founder of Carenodes, Alex has led efforts to integrate nonmedical services into healthcare, promoting a biopsychosocial model that focuses on holistic patient well-being. This initiative has reached 51 million Americans, supported by $1.5 billion in funding for innovative healthcare technologies.

In his role as Enterprise Leader for Value-Based Care and Payer Contracting at Mahmee, Alex spearheaded national expansion and contracting initiatives, negotiating partnerships with major payers across 43 states, saving $58 million for a Medicaid plan by reducing C-section rates.

His strategic insights have also driven significant operational efficiencies at Neuroglee Therapeutics, where as Senior VP, he enhanced Alzheimer’s and cognitive care services through digital therapeutics, expanding payer networks by 95%.

Alex’s career is marked by a commitment to healthcare as a right, advocating for patient-centered, equitable healthcare systems. His educational background includes a Master’s in Healthcare Administration from California State University, Long Beach, and a Bachelor’s in Psychology from the University of California, Riverside.